Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1989 | 12-1988 | 12-1987 | 12-1986 | 12-1985 | |
| Sales | 2,780 | 2,537 | 1,684 | 95 | 329 |
| Cost of Goods | 1,253 | 1,459 | 1,256 | 261 | 50 |
| Gross Profit | 1,527 | 1,077 | 429 | -166 | 279 |
| Operating Expenses | 6,957 | 7,367 | 4,747 | 1,062 | 2,019 |
| Operating Income | -5,177 | -5,830 | -4,063 | -967 | -1,690 |
| Interest Expense | 258 | 250 | 321 | 62 | 0 |
| Other Income | 926 | 1,099 | 542 | 100 | 142 |
| Pre-tax Income | -4,509 | -4,981 | -3,841 | -929 | -1,548 |
| Income Tax | 7 | 7 | 0 | 0 | 0 |
| Net Income Continuous | -4,516 | -4,988 | -3,841 | -929 | -1,548 |
| Net Income | $-4,516 | $-4,988 | $-3,841 | $-929 | $-1,548 |
| EPS Basic Total Ops | -38.07 | -44.48 | -54.24 | -27.61 | -58.19 |
| EPS Basic Continuous Ops | -37.98 | -43.87 | -54.24 | -27.90 | -58.19 |
| EPS Diluted Total Ops | -37.98 | -43.87 | N/A | -27.90 | -58.19 |
| EPS Diluted Continuous Ops | -37.98 | -43.87 | N/A | -27.90 | -58.19 |
| EBITDA(a) | $-4,485 | $-4,761 | $-3,166 | $-868 | $-1,690 |